BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Benedini S, Luzi L. Lipodystrophy HIV-related and FGF21: A new marker to follow the progression of lipodystrophy? J Transl Int Med 2016;4:150-4. [PMID: 28191538 DOI: 10.1515/jtim-2016-0026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Eckard AR, Hughes HY, Hagood NL, O'Riordan MA, Labbato D, Kosco JC, Scott SE, McComsey GA. Fibroblast Growth Factor 21 Is Elevated in HIV and Associated With Interleukin-6. J Acquir Immune Defic Syndr 2020;83:e30-3. [PMID: 31913998 DOI: 10.1097/QAI.0000000000002285] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Geller S, Arribat Y, Netzahualcoyotzi C, Lagarrigue S, Carneiro L, Zhang L, Amati F, Lopez-mejia IC, Pellerin L. Tanycytes Regulate Lipid Homeostasis by Sensing Free Fatty Acids and Signaling to Key Hypothalamic Neuronal Populations via FGF21 Secretion. Cell Metabolism 2019;30:833-844.e7. [DOI: 10.1016/j.cmet.2019.08.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
3 Iacob SA, Iacob DG. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown. Front Endocrinol 2022;13:814209. [DOI: 10.3389/fendo.2022.814209] [Reference Citation Analysis]
4 Gencer B, Pagano S, Vuilleumier N, Satta N, Delhumeau-Cartier C, Meier C, Bavamian S, Montecucco F, Mach F, Calmy A. Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients naïve of statin therapy: A cross-sectional analysis from the Swiss HIV cohort. Atherosclerosis 2019;284:253-9. [PMID: 30827714 DOI: 10.1016/j.atherosclerosis.2019.02.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]